Jacobson Pharma Announces FY2023 Interim Results

Profit Attributable to Shareholders Increases by Over 70% Declares Interim Dividend of HK2.8 Cents Per Share Solid Growth Momentum Bolstered by Healthcare Demand Jacobson...

Malaysian Genomics Sees Rise in Profit Margins for 1Q

Group seeks investment opportunities to expand reach of products and services Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today reported a...

EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly Driven by Medical...

Continue to Bolster Resilience with Diversified Healthcare Business Strategy Further Consolidating the Healthcare Services Market EC Healthcare (the Company, which together with its subsidiaries...

Perfect Medical Announces Interim Results for FY2022/23

Maintained decent profitability amid consumption slowdown and Covid-19 shadow Perfect Medical Health Management Limited (the Company , HKG: 1830), one of the largest aesthetic medical...

InaVac gets emergency approval from BPOM

The Food and Drug Supervisory Agency (BPOM) has issued emergency use authorization (EUA) for InaVac, a COVID-19 vaccine developed by researchers from Airlangga University...

CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again

China Resources Pharmaceutical Group Limited (CR Pharmaceutical or the Group) (HKG: 3320) has announced that the Group will once again be included as a...

Healthcare and Medical Leaders Gather to Shape the Future of Global Health

New research and innovations in Hong Kong and the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) are injecting new momentum and creating new opportunities for...

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT...

Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022, and Novotech's Chief Commercial Officer Barry Murphy is Session Chair...

Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue...

Prenetics Global Limited (NASDAQ: PRE) (Prenetics or the Company), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for...
HKTDC

Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK...

Global healthcare collaboration and innovation are key themes of the Hong Kong Trade Development Council (HKTDC)'s inaugural International Healthcare Week, currently taking place at...

Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round

Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as PureFDA) announced the completion of the Series B round of financing of over...

Bintai Kinden Ventures into Telco through Agreement with MN Permai Netcom

Company's subsidiary JMI partners with Telco Specialist to install telco infrastructure in hospitals Bintai Kinden Corporation Berhad (Bursa: BINTAI, 6998), a mechanical and electrical...

Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX

On November 4, 2022, Legend Capital portfolio company Giant Biogene (HKG: 2367) was successfully listed on the main board of the Hong Kong Stock...

Handover of National Centre for Pandemic and Infection Diseases in Myanmar; Advanced Facility Built...

The modern medical centre at Wai Bar Gi Hospital in Yangon will provide specialist treatment of pandemic and infectious diseases for all Myanmar...

SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company

SinoMab BioScience Limited (SinoMab or the Company, together with its subsidiaries, the Group, HKG: 3681), a Hong Kong-based biopharmaceutical company dedicated to the research,...

Led by Legend Capital, ClinBrain Completes Nearly CNY200 million Series C Round

Recently, the healthcare big data leader ClinBrain completed the Series C round of financing of nearly CNY200 million, led by Legend Capital. This round...

Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round

Shanghai Easy-Flow (Easy-Flow) recently completed its Angel financing round by raising tens of millions of CNY, led by Legend Capital. The fresh capital will...

Zhaoke Ophthalmology’s Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002...

Preliminary data from landmark, three-year, international study demonstrate safety and efficacy of NVK002 as a potential treatment for the progression of myopia in children Zhaoke...

Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE

Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced the signing of a Strategic Collaboration Agreement (SCA)...

Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper

Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest China biotech landscape analysis with expert guidance on pathways to...